OBJECTIVE: We sought to examine outcomes of mifepristone and misoprostol for early pregnancy failure (EPF) treatment in a nonresearch setting. STUDY DESIGN: A protocol was developed for physicians to use mifepristone 200 mg orally and misoprostol 800 μg vaginally for EPF. Success rates were analyzed and an adjusted multivariable regression was used to identify factors predictive of success. RESULTS: Treatment success occurred in 99 (80%; 95% confidence interval, 72-87%) of 123 patients after mifepristone and a single dose of misoprostol and 102 (83%; 95% confidence interval, 75-89%) patients overall. The odds of successful medical treatment were increased in women with a diagnosis of intrauterine embryonic/fetal demise (odds ratio, 3.80) and decreased in women who made additional emergency department visits (odds ratio, 0.12). CONCLUSION: Patients and clinicians may be more likely to intervene surgically with an EPF when a strict study protocol is not being followed.
OBJECTIVE: We sought to examine outcomes of mifepristone and misoprostol for early pregnancy failure (EPF) treatment in a nonresearch setting. STUDY DESIGN: A protocol was developed for physicians to use mifepristone 200 mg orally and misoprostol 800 μg vaginally for EPF. Success rates were analyzed and an adjusted multivariable regression was used to identify factors predictive of success. RESULTS: Treatment success occurred in 99 (80%; 95% confidence interval, 72-87%) of 123 patients after mifepristone and a single dose of misoprostol and 102 (83%; 95% confidence interval, 75-89%) patients overall. The odds of successful medical treatment were increased in women with a diagnosis of intrauterine embryonic/fetal demise (odds ratio, 3.80) and decreased in women who made additional emergency department visits (odds ratio, 0.12). CONCLUSION:Patients and clinicians may be more likely to intervene surgically with an EPF when a strict study protocol is not being followed.
Authors: Courtney A Schreiber; Mitchell D Creinin; Jessica Atrio; Sarita Sonalkar; Sarah J Ratcliffe; Kurt T Barnhart Journal: N Engl J Med Date: 2018-06-07 Impact factor: 91.245
Authors: Anne N Flynn; Jade M Shorter; Andrea H Roe; Sarita Sonalkar; Courtney A Schreiber Journal: Contraception Date: 2021-04-22 Impact factor: 3.051
Authors: Luís Guedes-Martins; Joaquim P Saraiva; Ana R Gaio; Ana Reynolds; Filipe Macedo; Henrique Almeida Journal: BMC Pregnancy Childbirth Date: 2015-02-13 Impact factor: 3.007
Authors: Marianne A C Verschoor; Marike Lemmers; Malu Z Wekker; Judith A F Huirne; Mariëtte Goddijn; Ben Willem J Mol; Willem M Ankum Journal: Obstet Gynecol Int Date: 2014-11-04
Authors: V Colleselli; T Nell; T Bartosik; C Brunner; A Ciresa-Koenig; L Wildt; C Marth; B Seeber Journal: Arch Gynecol Obstet Date: 2016-08-23 Impact factor: 2.344
Authors: Joyce van den Berg; Charlotte C Hamel; Marcus P Snijders; Sjors F Coppus; Frank P Vandenbussche Journal: BMC Pregnancy Childbirth Date: 2019-11-27 Impact factor: 3.007